{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:23:55Z","timestamp":1773321835448,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2,124,789"],"award-info":[{"award-number":["2,124,789"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012615","name":"University of Texas Health Science Center at Houston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AG079847"],"award-info":[{"award-number":["U01AG079847"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01LM014520"],"award-info":[{"award-number":["R01LM014520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA274576"],"award-info":[{"award-number":["U01CA274576"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01LM013712"],"award-info":[{"award-number":["R01LM013712"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01TR002062"],"award-info":[{"award-number":["U01TR002062"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG066749"],"award-info":[{"award-number":["R01AG066749"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG084637"],"award-info":[{"award-number":["R01AG084637"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG082721"],"award-info":[{"award-number":["R01AG082721"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.tjpad.2026.100483","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:57:37Z","timestamp":1768982257000},"page":"100483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The influence of bapineuzumab and semagacestat on rapid progressors: A retrospective cohort study"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1250-6650","authenticated-orcid":false,"given":"Kristofer","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-1868","authenticated-orcid":false,"given":"Madison","family":"Shyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7620-4984","authenticated-orcid":false,"given":"Elizabeth","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7082-2030","authenticated-orcid":false,"given":"Matias","family":"Cattani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2789-0993","authenticated-orcid":false,"given":"Catherine","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2572-7345","authenticated-orcid":false,"given":"Christine M.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0676-002X","authenticated-orcid":false,"given":"Paul E.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.tjpad.2026.100483_bib0001","article-title":"Deep learning to predict rapid progression of Alzheimer\u2019s disease from pooled clinical trials: A retrospective study","volume":"3","author":"Ma","year":"2024","journal-title":"PLOS Digit Health [Internet]"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100483_bib0002","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ncl.2007.04.001","article-title":"Rapidly Progressive Dementia","volume":"25","author":"Geschwind","year":"2007","journal-title":"Neurol Clin [Internet]"},{"issue":"6","key":"10.1016\/j.tjpad.2026.100483_bib0003","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41582-022-00659-0","article-title":"Rapidly progressive dementias \u2014 aetiologies, diagnosis and management","volume":"18","author":"Hermann","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"10.1016\/j.tjpad.2026.100483_bib0004","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archneurol.2011.189","article-title":"Rapidly Progressive Alzheimer Disease","volume":"68","author":"Schmidt","year":"2011","journal-title":"Arch Neurol [Internet]"},{"key":"10.1016\/j.tjpad.2026.100483_bib0005","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/CIA.S325026","article-title":"Role of Aducanumab in the Treatment of Alzheimer\u2019s Disease: Challenges and Opportunities","volume":"17","author":"Vaz","year":"2022","journal-title":"Clin Interv Aging [Internet]"},{"issue":"8","key":"10.1016\/j.tjpad.2026.100483_bib0006","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer 19s Dement [Internet]"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100483_bib0007","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N Engl J Med [Internet]"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100483_bib0008","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer\u2019s Disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N Engl J Med [Internet]"},{"key":"10.1016\/j.tjpad.2026.100483_bib0009","unstructured":"Study details | Effects of LY450139, on the progression of Alzheimer\u2019s disease as compared With Placebo | ClinicalTrials.gov [Internet]. [cited 2025 Jul 8]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00762411#publications."},{"key":"10.1016\/j.tjpad.2026.100483_bib0010","unstructured":"Study details | Effect of LY450139 on the long term progression of Alzheimer\u2019s disease | ClinicalTrials.gov [Internet]. [cited 2025 Jul 8]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00594568."},{"issue":"523","key":"10.1016\/j.tjpad.2026.100483_bib0013","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/01621459.2017.1319839","article-title":"Estimation and inference of heterogeneous treatment effects using random forests","volume":"113","author":"Wager","year":"2018","journal-title":"J Am Stat Assoc [Internet]"},{"key":"10.1016\/j.tjpad.2026.100483_bib0014","article-title":"Characterizing treatment non-responders vs. responders in completed Alzheimer\u2019s disease clinical Trials","author":"Wang","year":"2023","journal-title":"medRxiv [Internet]"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100483_bib0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1533317515617720","article-title":"Rapidly versus slowly progressing patients with Alzheimer\u2019s disease: Differences in baseline cognition","volume":"31","author":"Seidl","year":"2015","journal-title":"Am J Alzheimers Dis Other Demen [Internet]"},{"key":"10.1016\/j.tjpad.2026.100483_bib0016","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2019.05.031","article-title":"Sex differences in Alzheimer\u2019s disease: Understanding the molecular impact","volume":"1719","author":"Toro","year":"2019","journal-title":"Brain Res [Internet]"},{"issue":"6","key":"10.1016\/j.tjpad.2026.100483_bib0017","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archpsyc.62.6.685","article-title":"Sex differences in the clinical manifestations of Alzheimer disease pathology","volume":"62","author":"Barnes","year":"2005","journal-title":"Arch Gen Psychiatry [Internet]"},{"issue":"20","key":"10.1016\/j.tjpad.2026.100483_bib0018","first-page":"e2114","article-title":"Accelerated brain volume loss caused by Anti\u2013\u03b2-amyloid drugs: A systematic review and meta-analysis","volume":"100","author":"Alves","year":"2023","journal-title":"Neurol [Internet]"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100483_bib0019","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimer 19s Dis [Internet]"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100483_bib0020","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimer 19s Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100483_bib0021","article-title":"A phase III randomized trial of gantenerumab in prodromal Alzheimer\u2019s disease","volume":"9","author":"Ostrowitzki","year":"2017","journal-title":"Alzheimers Res Ther [Internet]"},{"key":"10.1016\/j.tjpad.2026.100483_bib0022","unstructured":"Alzheimer, Association. Alzheimer\u2019s association 2024 Alzheimer\u2019s disease facts and figures. 2023."},{"issue":"10","key":"10.1016\/j.tjpad.2026.100483_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/psp.2013.54","article-title":"Modeling Alzheimer\u2019s disease progression using disease onset time and disease trajectory concepts applied to CDR-SOB scores from ADNI","volume":"2","author":"Delor","year":"2013","journal-title":"CPT Pharmacomet Syst Pharmacol [Internet]"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:38:58Z","timestamp":1773261538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580726000075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2274580726000075"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100483","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of bapineuzumab and semagacestat on rapid progressors: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100483"}}